In metabolic syndrome mice, the CCL4 inhibition group had lower levels of HOMA-IR than the IgG control group (CCL4 inhibition for 4 weeks group (89.33 ± 11.41) vs. DM+IgG group (161.17 ± 14.52), P<0.01). The gene discussed is CCL4; the disease is metabolic syndrome.